This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Addressing Systemic Inequities and Structural Racism to Advance Health Equity for Latinos
Dr. Marcella Nunez-Smith is an internal medicine physician, the Associate Dean for Health Equity Research at Yale School of Medicine, and the Associate Director for Community Outreach and Engagement at the Cancer Center. Dr. Nunez-Smith served as chair of the Presidential COVID-19 Health Equity Task Force, and is one of the nation's foremost experts on disparities in healthcare access. Health Disparities Affecting Marginalized Communities Dr. ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Healthcare inequity in the Latinx community
The United States healthcare system is rife with systemic inequities affecting the Latinx community, the largest ethnic minority in the country with a population of 60.6 million [Estrada]. Health disparities include higher rates of infant mortality, stroke, cancer, heart disease, diabetes, hypertension, and COVID-19, and are often rooted in systemic racism and unconscious bias. [Webb Hooper, Duma] Latinx patients, especially those who are uncomfortable discussing care in English, are often stereotyped ...
U.S. Latinos face heavier burdens of stomach, liver, and cervical cancers, and worse outcomes for many cancers, than their White peers. But why? Unfortunately, many factors cause these disparities, from poverty and a lack of healthcare access to cultural barriers, acculturation, and genetic heritage. That's why it takes everyone working together to address Latino cancer. To this end, UT Health San Antonio has published a new open-access book, Advancing the Science of Cancer in Latinos: Building Collaboration for Action. The book is a collection of articles based on presentations at the 2nd biennial Advancing the Science of Cancer in Latinos conference on Feb. 26-28, 2020, in San Antonio, co-hosted by Mays Cancer Center and the Institute for Health Promotion Research (IHPR) ...
We’re all busy with the hustle and bustle of life. It’s tempting to grab fast food or buy ready-to-eat food to avoid cooking after a long day. But choosing those ultra-processed foods may cost you more than the money in your wallet. We already know that processed food is bad for your health, but an August 2022 study in The BMJ suggests that consuming ultra-processed food may increase risk for a serious disease – colorectal cancer. Let’s unpack these study results and what they mean for Latinos.
What Are Ultra-Processed Foods?
Ultra-processed foods – industrial ready-to-eat or ready-to-heat formulations made of little or no whole foods – now contribute 57% of total daily calories consumed by American adults, according to the study. These foods are usually rich ...
HPV-associated throat cancer is on the rise in men. With the typical patient being 50 to 60 years old, Black and Latino men are dying from the disease at higher rates than their white counterparts, regardless of the stage of diagnosis or the type of treatment they receive. These staggering statistics come from a 2022 study published in the Annals of Cancer Epidemiology. Here’s what you need to know about HPV-associated throat cancer, and what you can do to help prevent it.
What Causes HPV-Associated Throat Cancer?
HPV is short for human papillomavirus and is the most common sexually transmitted infection in the US, according to the Centers for Disease Control & Prevention. There are many types of HPVs, some of which can cause cancer later in life, according to ...
Timothy Leech just celebrated his 40th birthday when he got news that changed his life. Timothy was diagnosed with Stage 4 squamous cell carcinoma, a form of skin cancer, in 2014. Doctors told him he had only a short time to live. “I freaked out, for sure. I thought I was going to be gone real quick,” Timothy said. But, today, eight years later, Timothy is a cancer survivor. He credits his wife, Katie Leech, his medical team, and a clinical trial for getting him to where he is today – not entirely cancer-free but “so small that it’s immeasurable.” A clinical trial is a research study that helps researchers learn more to help slow, manage, and treat diseases like cancer. “It was very much like, this [clinical trial] is the last roll of the dice here,” ...
Timothy Leech acababa de celebrar su cumpleaños número 40, cuando recibió una noticia que cambió su vida. Timothy fue diagnosticado con carcinoma de células escamosas en etapa 4, una forma de cáncer de piel, en 2014. Los médicos le dijeron que le quedaba poco tiempo de vida. “Claro que me asusté, Pensé que me iba a ir muy rápido", dijo Timothy. Pero hoy, ocho años después, Timothy es un sobreviviente de cáncer. Él le da crédito a su esposa, Katie Leech, a su equipo médico y a un estudio clínico por llevarlo a donde está hoy, no completamente libre de cáncer, pero "tan pequeño que no se puede medir". Un estudio clínico es un estudio de investigación que ayuda a los investigadores a aprender más para ayudar a reducir el progreso, controlar y tratar ...
Leonel Rodriguez got some terrible news in November 2019. Doctors diagnosed Rodriguez, a South Texas resident, with mantle cell lymphoma – an aggressive, rare form of non-Hodgkin lymphoma. After going through several treatment options, his disease persisted. He soon learned about a potentially beneficial clinical trial for lymphoma patients at the Mays Cancer Center at UT Health San Antonio. Clinical trials help researchers learn how to better slow, manage, and treat diseases like cancer and Alzheimer’s. “[Clinical trials were] the best way because, you know, I feel good now with the treatment,” Rodriguez said. “Now I feel I've been feeling well, and well, well.”
Rodriguez’s Decision to Participate in a Clinical Trial
Rodriguez first experienced problems in ...
Leonel Rodríguez recibió una noticia terrible en noviembre de 2019. Los médicos diagnosticaron a Rodríguez, un residente del sur de Texas, con linfoma de células del manto, una forma agresiva y rara de linfoma no Hodgkin. Los primeros medicamentos que tomó para tratar el cáncer en realidad empeoraron su condición. Pronto se enteró de un estudio clínico potencialmente beneficioso para pacientes con linfoma ofrecido por el Mays Cancer Center de UT Health San Antonio. Los estudios clínicos ayudan a los investigadores a aprender cómo reducir el progreso, manejar y tratar mejor enfermedades como el cáncer y el Alzheimer. "[Los estudios clínicos fueron] la mejor manera porque, usted sabe, ahora me siento bien con el tratamiento", dijo Rodríguez. "Ahora siento que me ...
